TET2 might be a therapeutic target for atherosclerosis

被引：1
|
作者：
Wang, Yu [1 ]
Zhao, Danyang [2 ]
Lu, Ping [1 ]
Sheng, Jing [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Geriatr, Shanghai 200011, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, Shanghai 200011, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2016年 / 203卷
关键词：
DNA METHYLATION;
D O I：
10.1016/j.ijcard.2015.10.052
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：396 / 397
页数：2
相关论文
共 50 条
  • [41] FISH screening for TET2 deletions
    Kotzampaltiris, Paul
    Zareian, N.
    Brazma, D.
    Gancheva, K.
    Howard-Reeves, J.
    Grace, C.
    Nacheva, E.
    JOURNAL OF MEDICAL GENETICS, 2012, 49 : S44 - S44
  • [42] TET2 keeps histones sweet
    Katharine H. Wrighton
    Nature Reviews Molecular Cell Biology, 2013, 14 : 64 - 65
  • [43] Blockade Of IL-6 Signaling Alleviates Atherosclerosis In Tet2 Deficient Clonal Hematopoiesis
    Liu, Wenli
    Wang, Nan
    Tall, Alan
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43
  • [44] Mutation in TET2 in Myeloid Cancers
    Tefferi, Ayalew
    Lim, Ken-Hong
    Levine, Ross
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (11): : 1117 - 1117
  • [45] TET2 keeps histones sweet
    Wrighton, Katharine H.
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2013, 14 (02) : 64 - 64
  • [46] Mutations in TET2 in myeloid cancers
    Bernard, Olivier A.
    Delhommeau, Francois
    Fontenay, Michaela
    Vainchenker, William
    M S-MEDECINE SCIENCES, 2009, 25 (10): : 785 - 788
  • [47] TET2 Mutation Associated Clonal Hematopoiesis is Linked to a TET2 Polymorphism in Acute Myeloid Leukemia Patients
    Brauer, Dominic
    Grimm, Juliane
    Jentzsch, Madlen
    Bill, Marius
    Goldmann, Karoline
    Schulz, Julia
    Niederwieser, Dietger
    Platzbecker, Uwe
    Schwind, Sebastian
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 108 - 109
  • [48] Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia
    Yamazaki, Jumpei
    Taby, Rodolphe
    Jelinek, Jaroslav
    Raynal, Noel J. M.
    Cesaroni, Matteo
    Pierce, Sherry A.
    Kornblau, Steven M.
    Bueso-Ramos, Carlos E.
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Issa, Jean-Pierre J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (02):
  • [49] First-in-class TET2 activator as a new therapeutic strategy to fight cancer
    Aguilar, D.
    Puig, I.
    Arques, O.
    Marcote, I.
    Cabellos, L.
    Chicote, I.
    Diaz, C.
    Palmer, H.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S48 - S48
  • [50] TET2 mutation in acute myeloid leukemia: biology, clinical significance, and therapeutic insights
    Gao, Qiang
    Shen, Kefeng
    Xiao, Min
    CLINICAL EPIGENETICS, 2024, 16 (01)
12345